Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Clinical Relevance of Biomarkers of Oxidative Stress (CROSBI ID 226410)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Frijhoff, Jeroen ; Winyard, Paul G. ; Zarkovic, Neven ; Davies, Sean S. ; Stocker, Roland ; Cheng, David ; Knight, Annie R. ; Emma Louise Taylor, Oettrich, Jeannette ; Ruskovska, Tatjana ; Cipak Gasparovic, Ana et al. Clinical Relevance of Biomarkers of Oxidative Stress // Antioxidants & redox signaling, 23 (2015), 14; 1144-1170. doi: 10.1089/ars.2015.6317

Podaci o odgovornosti

Frijhoff, Jeroen ; Winyard, Paul G. ; Zarkovic, Neven ; Davies, Sean S. ; Stocker, Roland ; Cheng, David ; Knight, Annie R. ; Emma Louise Taylor, Oettrich, Jeannette ; Ruskovska, Tatjana ; Cipak Gasparovic, Ana ; Cuadrado, Antonio ; Weber, Daniela ; Poulsen, Henrik Enghusen ; Grune, Tilman ; Schmidt, Harald H.H.W. ; Ghezzi, Pietro

engleski

Clinical Relevance of Biomarkers of Oxidative Stress

Significance: Oxidative stress is considered to be an important component of various diseases. A vast number of methods have been developed and used in virtually all diseases to measure the extent and nature of oxidative stress, ranging from oxidation of DNA to proteins, lipids, and free amino acids. Recent Advances: An increased understanding of the biology behind diseases and redox biology has led to more specific and sensitive tools to measure oxidative stress markers, which are very diverse and sometimes very low in abundance. Critical Issues: The literature is very heterogeneous. It is often difficult to draw general conclusions on the significance of oxidative stress biomarkers, as only in a limited proportion of diseases have a range of different biomarkers been used, and different biomarkers have been used to study different diseases. In addition, biomarkers are often measured using nonspecific methods, while specific methodologies are often too sophisticated or laborious for routine clinical use. Future Directions: Several markers of oxidative stress still represent a viable biomarker opportunity for clinical use. However, positive findings with currently used biomarkers still need to be validated in larger sample sizes and compared with current clinical standards to establish them as clinical diagnostics. It is important to realize that oxidative stress is a nuanced phenomenon that is difficult to characterize, and one biomarker is not necessarily better than others. The vast diversity in oxidative stress between diseases and conditions has to be taken into account when selecting the most appropriate biomarker

oxidative stress ; biomarker

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

23 (14)

2015.

1144-1170

objavljeno

1523-0864

10.1089/ars.2015.6317

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost